Skip to main content
Center of Excellence in Urology & Men's Health (Pattaya, Chonburi, Rayong)
TreatmentVideo Guide6 min read

Shockwave Therapy, PRP & Stem Cells for Erectile Dysfunction: What 2025–2026 Clinical Trials Actually Show

Dr. Niti reviews the latest Cochrane 2025, EAU 2026, and placebo-controlled trial evidence comparing Low-Intensity Shockwave Therapy, PRP injections, and Stem Cells for ED—plus Thai Medical Council & FDA clinical study rules.

Shockwave Therapy, PRP & Stem Cells for Erectile Dysfunction: What 2025–2026 Clinical Trials Actually Show
Specialist Video Guide · Dr. Niti Navanimitkul

Shockwave Therapy, PRP and Stem Cells for Erectile Dysfunction (ED): What the Evidence Says

@Dr.Niti-ProstateMensHealth

Video Chapters & Key Moments (Click to Jump)

Evidence-Based Clinical Summary (EAU 2026 & Cochrane 2025)

  • Low-Intensity Shockwave (Li-ESWT): 21 sham-controlled trials (1,357 men, Cochrane 2025); modest benefit in selected mild vasculogenic ED peaking 1–3 months post-course (EAU 2026 weak recommendation).
  • PRP Injections: 7-trial placebo-controlled meta-analysis (J Sex Med 2026) found no reliable advantage over saline; EAU 2026 restricts to clinical trials.
  • Stem Cells: Largest RCT in 70 post-prostatectomy men (Eur Urol Focus 2026) showed no 12-month benefit; in Thailand, restricted strictly to approved non-commercial clinical trials.

Oral ED tablets boost nitric-oxide signaling temporarily without repairing cavernosal blood vessels or nerves—so many men ask whether "regenerative" treatments truly cure ED. Upholding the highest standards of medical honesty and E-E-A-T transparency, Dr. Niti Navanimitkul (ว.29673) synthesizes eight landmark peer-reviewed sources—including EAU 2026 Guidelines, Cochrane 2025, and 2026 randomized trials—so patients can make informed, hype-free decisions.

Side-by-Side Comparison of Regenerative vs. Proven ED Modalities

Modality Human Trial Evidence EAU 2026 / Regulatory Status
Low-Intensity Shockwave (Li-ESWT) 21 sham RCTs (1,357 men); small average gain in mild vascular ED Weak recommendation for selected men; mild/uncommon side effects
PRP Intracavernosal Injection Mixed RCTs; 2026 7-trial meta-analysis showed no clear gain vs placebo Clinical studies only (can still cause bruising or micro-scarring)
Stem Cell Therapy 70-man post-RP RCT (2026) showed no benefit at 12 months Clinical trials only; Thai Medical Council/FDA forbid commercial charging/ads

The Bottom Line: Because ED can be the earliest sign of heart disease, diabetes, or low testosterone, always start with a medical evaluation. Oral PDE5 inhibitors come first, followed by Focused Shockwave Therapy for selected mild vascular cases, and proven second/third-line solutions including vacuum devices, intracavernosal injections, and Inflatable Penile Implants. Consult Dr. Niti in Pattaya for an honest, evidence-driven plan.

Frequently Asked Clinical Questions

Does Low-Intensity Shockwave Therapy (Li-ESWT) really improve erections according to Cochrane & EAU guidelines?
Shockwave therapy has the strongest human data of the three regenerative modalities (21 sham-controlled trials in 1,357 men, Cochrane 2025). In selected men with mild vasculogenic ED, it can produce a modest improvement appearing 1–3 months after a course (classically 12 painless 15-minute sessions), and EAU 2026 guidelines list it as a weak recommendation for selected patients.
What do 2026 randomized trials show about PRP (P-Shot) injections for ED?
Individual placebo-controlled PRP trials have disagreed, and a 2026 meta-analysis combining 7 placebo-controlled trials (de Amorim et al., J Sex Med 2026) found no reliable benefit over saline placebo. EAU 2026 guidelines recommend PRP within clinical studies only.
What is the evidence and Thai regulatory status for Stem Cell therapy in ED?
While animal studies showed growth-factor release, the largest placebo-controlled human trial (70 post-prostatectomy men, Eur Urol Focus 2026) showed no benefit at 12 months. Under Medical Council of Thailand, DHSS, and Thai FDA rules, stem cells for ED are permitted strictly within approved clinical studies without commercial advertising or patient charges.

Ready to Start?